Full View

CADD v1. 7: using protein language models, regulatory CNNs and other nucleotide-level scores to improve genome-wide variant predictions

M Schubach, T Maass, L Nazaretyan… - Nucleic acids …, 2024 - academic.oup.com
Abstract Machine Learning-based scoring and classification of genetic variants aids the
assessment of clinical findings and is employed to prioritize variants in diverse genetic …
被引用次数：24 相关文章

CADD v1. 7: using protein language models, regulatory CNNs and other nucleotide-level scores to improve genome-wide variant predictions.

M Schubach, T Maass, L Nazaretyan… - Nucleic Acids …, 2024 - europepmc.org
Abstract Machine Learning-based scoring and classification of genetic variants aids the
assessment of clinical findings and is employed to prioritize variants in diverse genetic …

CADD v1. 7: using protein language models, regulatory CNNs and other nucleotide-level scores to improve genome-wide variant predictions

M Schubach, T Maass, L Nazaretyan… - Nucleic acids …, 2024 - pubmed.ncbi.nlm.nih.gov
Machine Learning-based scoring and classification of genetic variants aids the assessment
of clinical findings and is employed to prioritize variants in diverse genetic studies and …
[HTML] nih.gov

[HTML][HTML] CADD v1. 7: using protein language models, regulatory CNNs and other nucleotide-level scores to improve genome-wide variant predictions

M Schubach, T Maass, L Nazaretyan… - Nucleic Acids …, 2024 - ncbi.nlm.nih.gov
Abstract Machine Learning-based scoring and classification of genetic variants aids the
assessment of clinical findings and is employed to prioritize variants in diverse genetic …

CADD v1. 7: using protein language models, regulatory CNNs and other nucleotide-level scores to improve genome-wide variant predictions.

M Schubach, T Maass, L Nazaretyan… - Nucleic Acids …, 2024 - europepmc.org
Machine Learning-based scoring and classification of genetic variants aids the assessment
of clinical findings and is employed to prioritize variants in diverse genetic studies and …